Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency-Reference-Cited by-同舟云学术

Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency

Published:2015-03 Issue:4 Volume:51 Page:507-513
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Poprach Alexandr,Bortlicek Zbynek,Melichar Bohuslav,Lakomy Radek,Svoboda Marek,Kiss Igor,Zemanova Milada,Fiala Ondrej,Kubackova Katerina,Coufal Oldrich,Pavlik Tomas,Dusek Ladislav,Vyzula Rostislav,Buchler Tomas^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. IARC CancerBase no. 11 (online). International Agency for Research on Cancer, Lyon, France, 2012. Available from URL: http://globocan.iarc.fr [accessed on 30.07.14].

2. Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database;Poprach;Med Oncol,2012

3. Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registry;Buchler;Ann Oncol,2012

4. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

5. Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency;Khan;Ann Oncol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Kidney Function and Outcomes Following Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-04

2. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment;Urologic Oncology: Seminars and Original Investigations;2023-11

3. Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment;Cancer Chemotherapy and Pharmacology;2022-04-20

4. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 2019;Asia-Pacific Journal of Clinical Oncology;2021-04

5. Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure;Current Drug Metabolism;2019-06-20